- Home
- MRK vs MBINN Comparison
MRK vs MBINN Comparison
Compare MRK & MBINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | MBINN |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | N/A |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MRK | MBINN |
|---|---|---|
| Price | $146.58 | $19.68 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $125.59 | N/A |
| AVG Volume (30 Days) | ★ 6.4M | 6.6K |
| Earning Date | 04-30-2026 | N/A |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ 2.73 |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.61 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | ★ N/A | $7.29 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $77.58 | $18.27 |
| 52 Week High | $157.00 | $21.45 |
Technical Indicators
Market Signals| Indicator | MRK | MBINN |
|---|---|---|
| Relative Strength Index (RSI) | 54.47 | 50.51 |
| Support Level | $145.75 | $19.81 |
| Resistance Level | $152.80 | $20.27 |
| Average True Range (ATR) | 2.64 | 0.23 |
| MACD | -1.12 | -0.00 |
| Stochastic Oscillator | 39.50 | 82.61 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About MBINN Merchants Bancorp
Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.